CBGA has anticonvulsant effects against hyperthermia-induced seizures in the Scn1a+/- mouse model of Dravet syndrome. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.